AI Issuer Brief
ClaudeLoading cached brief…
Peers
- RVMDRevolution Medicines, Inc.$139.48$29.65B
- ALGNAlign Technology, Inc.$178.91$12.81B
- ENSGThe Ensign Group, Inc.$183.72$10.73B
- UHSUniversal Health Services, Inc.$167.00$10.46B
- BMRNBioMarin Pharmaceutical Inc.$54.06$10.4B
- MOHMolina Healthcare, Inc.$192.70$10.04B
- HSICHenry Schein, Inc.$73.93$8.48B
- ATRAptarGroup, Inc.$119.02$7.66B
Price change · trailing returns
Live · FMP| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.39% | -2.54% | +25.28% | +24.35% | +62.40% | +71.08% | +44.60% | +107.49% | +62.16% | +151.37% | +4669.57% |
Aftermarket
Live · FMPLast trade
$194.55
222 sh
Bid
$193.00
9 sh
Ask
$198.35
200 sh
Spread
$5.350
Fair value
Football field →Weighted blend
$2,058.61
+959.18% vs spot
Recommendation
Strong Buy
14 of 16 methods
Method spread
12bull2bear
±5% threshold
Analyst PT consensus: $168.67 (-13.22%)
Total assets
$17.48B
Total debt
$15.05B
Cash & equiv
$757.75M
Operating CF
$1.89B
Free cash flow
$1.31B
Buybacks
-$1.79B
Analyst view
DB · price_targets + analyst_gradesConsensus target
$168.67
-13.22% upside
Low
$158.00
Median
$158.00
High
$190.00
Recent actions
0 ↑0 ↓8 hold
- Apr 01, 2026
- Mar 01, 2026
- Feb 01, 2026
- Jan 01, 2026
- Dec 01, 2025
News
DB · news_items- DaVita Inc. (DVA) Presents at Bank of America Global Healthcare Conference 2026 Transcriptseekingalpha.com·May 12, 2026
- Here's Why DaVita HealthCare (DVA) is a Strong Momentum Stockzacks.com·May 12, 2026
- DaVita Inc. to Participate in the BofA Securities 2026 Health Care Conferenceprnewswire.com·May 06, 2026
- DaVita Inc. 1st Quarter 2026 Resultsprnewswire.com·May 05, 2026
- Here is What to Know Beyond Why DaVita Inc. (DVA) is a Trending Stockzacks.com·May 01, 2026
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q4 Dec 2025 | $3.62B | $234.22M | $2.45 |
| Q3 Sep 2025 | $3.42B | $150.33M | $2.04 |
| Q2 Jun 2025 | $3.38B | $199.34M | $2.58 |
| Q1 Mar 2025 | $3.22B | $162.92M | $2.00 |
| Q4 Dec 2024 | $3.29B | $259.33M | $3.09 |
| Q3 Sep 2024 | $3.26B | $214.69M | $2.50 |
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
Maughan David Paul officer: Chief Operating Officer, DKC | Sell | 13,456 | $2.68M | May 12, 2026 |
Maughan David Paul officer: Chief Operating Officer, DKC | Sell | 7,073 | $1.41M | May 11, 2026 |
BERKSHIRE HATHAWAY INC 10 percent owner | Sell | 1M | $182.86M | May 01, 2026 |
BERKSHIRE HATHAWAY INC 10 percent owner | Sell | 2M | $199.94M | Jan 29, 2026 |
BERKSHIRE HATHAWAY INC 10 percent owner | Sell | 401,514 | $54.35M | Oct 27, 2025 |
BERKSHIRE HATHAWAY INC 10 percent owner | Sell | 2M | $230.02M | Jul 31, 2025 |
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|---|---|---|---|---|
| FY 2025 | $13.64B | $2.01B | $746.8M | $9.51 | +5.47% |
| FY 2024 | $12.82B | $2.09B | $936.34M | $10.73 | +7.31% |
| FY 2023 | $12.14B | $1.6B | $691.54M | $7.42 | +5.70% |
| FY 2022 | $11.61B | $1.34B | $560.4M | $5.71 | +4.83% |
| FY 2021 | $11.62B | $1.8B | $978.45M | $8.90 | +8.42% |